Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical

Author of the article: Article content TORONTO, Oct. 14, 2024 (GLOBE NEWSWIRE) Psyence Group Inc (Psyence Group or the Company) (CSE: PSYG) hereby announces that it has entered into a debt-for-equi… [+11312 chars]

Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute
Majority of Children With Spinal Muscular Atrophy (SMA) Treated With Genentech's Evrysdi Are Able to Sit, Stand and Walk Independently, Two-Year Data Demonstrate
Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide

For Girls to Succeed in STEM, Confidence Matters as Much as Competence
Nektar Therapeutics (NASDAQ:NKTR) Receives $2.33 Average Price Target from Analysts